Siri Mjaaland

Senior Scientist/Professor

Norwegian Institute of Public Health

Norway

Research Interests

Explore related searches

Professors in Norway Professors in Immunology Immunology professors in Norway

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Siri Mjaaland is a Senior Scientist at the Norwegian Institute of Public Health in Norway. Her research focuses on the immune response to SARS-CoV-2, particularly in vulnerable populations such as patients receiving TNF inhibitors and those with inflammatory bowel disease. Dr. Mjaaland has contributed to various studies examining vaccination impacts on T cell responses, seroprevalence, and menstrual disturbances related to COVID-19 vaccination.

Articles (14)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Tore Kristian Kvien

Professor

University of Oslo

NORWAY

View details

John T. Vaage

Professor II

University of Oslo

NORWAY

View details

Gunnveig Grødeland

University of Oslo

NORWAY

View details

Anne Therese Tveter

University of Oslo

NORWAY

View details

Anders Åsberg

University of Oslo

NORWAY

View details

Espen Melum

Oslo University Hospital

NORWAY

View details

Ludvig A Munthe

professor

University of Oslo

NORWAY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Siri Mjaaland

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study

Characterization of the SARS-CoV-2 antibody landscape in Norway in the late summer of 2022: high seroprevalence in all age groups with patterns of primary Omicron infection in children and hybrid immunity in adults

T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients with inflammatory bowel disease on TNF inhibitor treatment, a prospective cohort study

Heavy bleeding and other menstrual disturbances in young women after COVID-19 vaccination

T cell responses to SARS-CoV-2 vaccination differ by disease-modifying therapy for multiple sclerosis

Determinants of humoral and cellular immune responses to three doses of mRNA SARS-CoV-2 vaccines in older adults: a longitudinal cohort study

Metabolomic analysis of maternal mid-gestation plasma and cord blood in autism spectrum disorders

Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants

Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study

Menstrual disturbances in 12- to 15-year-old girls after one dose of COVID-19 Comirnaty vaccine: Population-based cohort study in Norway

Unexpected vaginal bleeding and COVID-19 vaccination in nonmenstruating women

Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants

Effectiveness of mRNA Booster Vaccination Against Mild, Moderate, and Severe COVID-19 Caused by the Omicron Variant in a Large, Population-Based, Norwegian Cohort

Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy

Collaborators (7)

Tore Kristian Kvien

John T. Vaage

Gunnveig Grødeland

Anne Therese Tveter

Anders Åsberg

Espen Melum

Ludvig A Munthe

Make your next move.